Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.62 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.56 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.56 |
| ▸ | GNPAT | O15228 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | THPO | P40225 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.51 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.50 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20530 | 1.00 | FOLH1 (0.62) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| SCHEMBL919220 | 1.00 | FOLH1 (0.62) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| SCHEMBL31621383 | 0.98 | FOLH1 (0.60) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL15669796 | 0.98 | FOLH1 (0.60) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| SCHEMBL31621379 | 0.98 | FOLH1 (0.60) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| SCHEMBL31621381 | 0.98 | FOLH1 (0.60) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| SCHEMBL16238796 | 0.98 | FOLH1 (0.60) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| Ethylene SCHEMBL28796153 | 0.96 | FOLH1 (0.58) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| Glycine SCHEMBL17203937 | 0.95 | FOLH1 (0.61) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 | |
| Glycine SCHEMBL28267531 | 0.95 | FOLH1 (0.61) | FOLH1SIRT6SIRT1GNPATSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10313 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026098441-A1 | COMPOSITION AND METHOD FOR CANCER TREATMENT USING POLYPEPTIDE CONJUGATES | SUZHOU SMARTNUCLIDE BIOPHARMACEUTICAL CO., LTD. (CN) | 2026-05-15 | — | — | WO | claimed |
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| WO-2025245279-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USE THEREFORE IN TREATMENT OF ADDICTION AND/OR PAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245292-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USES THEREOF FOR MODULATING WEIGHT LOSS | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245294-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USES THEREOF FOR MODULATING WEIGHT GAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| EP-4633656-A1 | STAPLED PEPTIDES AND METHODS THEREOF | Parabilis Medicines, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4633657-A1 | STAPLED PEPTIDES AND METHODS THEREOF | Parabilis Medicines, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| WO-1992018156-A1 | BRADYKININ ANTAGONIST PEPTIDES | NOVA TECHNOLOGY LIMITED PARTNERSHIP (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0178911-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1992-01-22 | — | — | EP | claimed |
| EP-0199432-B1 | ASSAYING METHOD FOR PRIMARY AMINES USING AROMATIC DIALDEHYDES | OREAD LABORATORIES, INC. (US) | 1991-05-29 | — | — | EP | claimed |
| US-4910314-A | Containing a benz(f)isoindole ring | OREAD LABORATORIES, INC. (US) | 1990-03-20 | — | — | US | claimed |
| US-4910296-A | Polypeptide | MAX-PLANCK-GESELLSCHAFT ZUR FOEDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1990-03-20 | — | — | US | claimed |
| EP-0199432-A2 | Assaying method for primary amines using aromatic dialdehydes | OREAD LABORATORIES, INC. (US) | 1986-10-29 | — | — | EP | claimed |
| US-4612365-A | Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments | MAX-PLANCK-GESELLSCHAFT ZUR FOEDERUNG DER WISSENSCHAFTEN (DE) | 1986-09-16 | — | — | US | claimed |
| EP-0178911-A2 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1986-04-23 | — | — | EP | claimed |
| EP-0056594-B1 | THYMOSIN-ALPHA-1 FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS WITH IMMUNOREGULATING ACTION CONTAINING THEM | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1984-09-12 | — | — | EP | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |